-
Mashup Score: 59Proposed Changes to Federal Health Agencies Threaten Future Cancer Research Advancements - ASCO - 2 day(s) ago
The Association for Clinical Oncology (ASCO) is carefully reviewing the Administration’s Fiscal Year 2026 “skinny” budget proposal, which was released May 2 and contains significant cuts to federal health agencies under the Department of Health and Human Services (HHS), notably a 40% cut to the National Institutes of Health’s (NIH) overall budget. The president’s budget proposal outlines the Administration’s funding priorities; Congress is tasked with setting the federal budget. While the proposal
Source: www.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1
Welcome! You are invited to join a webinar: TAPUR Study Grand Rounds 2025. After registering, you will receive a confirmation email about joining the webinar.
Source: asco1.zoom.usCategories: General Medicine News, Partners & KOLsTweet-
Last chance to register for our TAPUR Grand Rounds webinar on May 6! Learn more about TAPUR Study results and impact & connect with the oncology community. Register today: https://t.co/pWfyr8ElC1 https://t.co/SdMtjDJD3R
-
-
Mashup Score: 13ASCO-SNO Guideline Update Addresses Use of Vorasidenib for Astrocytic and Oligodendroglial Tumors - 3 day(s) ago
ASCO and Society of Neuro-Oncology have released a rapid recommendation update to their joint guideline, addressing the use of vorasidenib in selected patients with grade 2 astrocytomas or oligodendrogliomas with a susceptible IDH1 or IDH2 mutation. The update is based on results of the phase 3 INDIGO trial, which showed that vorasidenib was associated with a significant improvement in PFS and a delay in the time to next intervention compared with placebo among this patient population.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
This week's update to our joint guideline w/ @NeuroOnc addresses using vorasidenib in selected pts w/ grade 2 astrocytomas or oligodendrogliomas w/ a susceptible IDH1/IDH2 mutation. #ASCODailyNews has more, including interviews with guideline co-chairs: https://t.co/gvktW4Wobf https://t.co/dHJq33FaKz
-
-
Mashup Score: 1Open Comment of Guidelines - ASCO - 3 day(s) ago
Open comment allows key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication. It allows for greater transparency in the ASCO guideline development process and complies with the Institute of Medicine (IOM) and Council for Medical Specialty Societies (CMSS) standards for guideline development. In addition, open comment enables ASCO to engage interested stakeholders (especially patients/patient advocacy groups), provide a higher-quali
Source: www.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
The draft guideline protocol, Systemic Therapy for Sarcoma, is now available for open comment. Provide your feedback to us by May 13. Find more details here: https://t.co/XKwFSsgQp7 https://t.co/V2eJDJybsG
-
-
Mashup Score: 6Open Comment of Guidelines - ASCO - 3 day(s) ago
Open comment allows key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication. It allows for greater transparency in the ASCO guideline development process and complies with the Institute of Medicine (IOM) and Council for Medical Specialty Societies (CMSS) standards for guideline development. In addition, open comment enables ASCO to engage interested stakeholders (especially patients/patient advocacy groups), provide a higher-quali
Source: www.asco.orgCategories: General Medicine NewsTweet-
The draft guideline protocol, Cancer Treatment During Pregnancy, is now available for open comment. Provide your feedback to us by May 13. Find more details here: https://t.co/g6y8rqNDf5 https://t.co/U6oZYGw9Fh
-
-
Mashup Score: 55
ASCO CEO Dr. Clifford A. Hudis welcomes the global cancer care community to participate in the 2025 ASCO Annual Meeting.
Source: connection.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
#ASCO25 is fast approaching! The meeting “is a unique & extraordinary opportunity for colleagues from our entire community to gather, review new [info] together, exchange best practices & drive defining advancements in #CancerCare,” writes @cliffordhudis. https://t.co/QCOyRYP1EU
-
-
Mashup Score: 26Open Comment of Guidelines - ASCO - 4 day(s) ago
Open comment allows key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication. It allows for greater transparency in the ASCO guideline development process and complies with the Institute of Medicine (IOM) and Council for Medical Specialty Societies (CMSS) standards for guideline development. In addition, open comment enables ASCO to engage interested stakeholders (especially patients/patient advocacy groups), provide a higher-quali
Source: www.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
The draft guideline protocol, Systemic Therapy for Sarcoma, is now available for open comment. Provide your feedback to us by May 13. Find more details here: https://t.co/XKwFSsgQp7 https://t.co/V2eJDJybsG
-
-
Mashup Score: 13
This clinical insights article is derived from recommendations in Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update. This document is based on an ASCO Guideline and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. This article does not purport to suggest any particular course of medical treatment. Use of the
Source: ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
Check out our new clinical insights on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults. This is a companion piece to the updated guideline, published online in @JCOOP_ASCO. Read full article: https://t.co/4i0LBaG0iU
-
-
Mashup Score: 12Registration Details - ASCO - 6 day(s) ago
location_on McCormick Place, Chicago, IL & Online Online registrations are processed securely and confirmed immediately by email. Below you will find information related to registration fees, special rate categories, registration changes, and cancellations. Want to receive your badge in the mail before the Meeting? Register by the early registration deadline! The ASCO Annual Meeting is cashless! If you would like to register onsite at the meeting, please contact our Meetings team if you need to use
Source: www.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
Recharge your passion for oncology; meet up with colleagues, mentors, and friends; and find out about the most clinically relevant science & hottest research topics in oncology at #ASCO25. The 2025 ASCO Annual Meeting is the place to be, learn more: https://t.co/MiWJTgcEgT https://t.co/ViMLfJ0ql3
-
-
Mashup Score: 37Celebrating the Volunteers Who Make ASCO’s Work Possible - 9 day(s) ago
2024-2025 ASCO president Dr. Robin Zon celebrates ASCO’s volunteers during Global Volunteer Month and National Volunteer Week.
Source: connection.asco.orgCategories: General Medicine News, Partners & KOLsTweet-
During this #GlobalVolunteerMonth & #NationalVolunteerWeek, our @ASCOPres, Dr. Robin Zon, honors & celebrates the impact of our many volunteers and announces our newest committee leaders. Read more: https://t.co/TUQHitlHok https://t.co/NEwr1XbKP9
-
ASCO is calling on lawmakers to uphold the U.S.’s role as a global leader in scientific and medical innovation and preserve vital federal cancer prevention and research funding. #ASCOAdvocacy Read our statement: https://t.co/6txS0eCFBd https://t.co/DoBDeXzDN1